Correlation Between Janux Therapeutics and Erytech Pharma
Can any of the company-specific risk be diversified away by investing in both Janux Therapeutics and Erytech Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Janux Therapeutics and Erytech Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Janux Therapeutics and Erytech Pharma SA, you can compare the effects of market volatilities on Janux Therapeutics and Erytech Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Janux Therapeutics with a short position of Erytech Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Janux Therapeutics and Erytech Pharma.
Diversification Opportunities for Janux Therapeutics and Erytech Pharma
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Janux and Erytech is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Janux Therapeutics and Erytech Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Erytech Pharma SA and Janux Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Janux Therapeutics are associated (or correlated) with Erytech Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Erytech Pharma SA has no effect on the direction of Janux Therapeutics i.e., Janux Therapeutics and Erytech Pharma go up and down completely randomly.
Pair Corralation between Janux Therapeutics and Erytech Pharma
If you would invest 4,501 in Janux Therapeutics on September 2, 2024 and sell it today you would earn a total of 20.00 from holding Janux Therapeutics or generate 0.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Janux Therapeutics vs. Erytech Pharma SA
Performance |
Timeline |
Janux Therapeutics |
Erytech Pharma SA |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Janux Therapeutics and Erytech Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Janux Therapeutics and Erytech Pharma
The main advantage of trading using opposite Janux Therapeutics and Erytech Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Janux Therapeutics position performs unexpectedly, Erytech Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Erytech Pharma will offset losses from the drop in Erytech Pharma's long position.Janux Therapeutics vs. Tff Pharmaceuticals | Janux Therapeutics vs. Eliem Therapeutics | Janux Therapeutics vs. Inhibrx | Janux Therapeutics vs. Enliven Therapeutics |
Erytech Pharma vs. Genfit | Erytech Pharma vs. Eliem Therapeutics | Erytech Pharma vs. HCW Biologics | Erytech Pharma vs. Aptorum Group Ltd |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
CEOs Directory Screen CEOs from public companies around the world | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |